Current Clinical Trials

Currently we are conducting the following Clinical Trial(s):

Idiopathic Hypersomnia Clinical Trial: Patients ages 18-75, with Idiopathic Hypersomnia. This study is looking at the effect of a new medicine on sleepiness in patients with Idiopathic Hypersomnia who have access to their previous test results confirming Idiopathic Hypersomnia. If they also have sleep apnea, it must be adequately treated. The study lasts about 40 weeks, with 13 office visits and one overnight stay. Subjects get active medicine throughout the study except for a two-week period during which they may get active medicine or placebo. We pay about $2000 for the subject’s time and expenses upon completing the study.
Narcolepsy Clinical Trial: Patients ages 18-50, with Narcolepsy. This study is looking at the effect of a new medicine on sleepiness in patients with Narcolepsy who have access to their previous test results confirming Narcolepsy. The study lasts about 5 weeks, with three sleep testing stays (overnight and the next day) with us. Patients may get active medicine or placebo. We pay $930 for the subject’s time and expenses upon completing the study.

Clinical trials come and go, and they fill up fast.

How do I participate?

Call our office at 586-254-0707, or fill out a request for us to contact you.

Safe Reopening After Covid-19 Peak We will reopen our office and sleep and EEG labs for on-site patient care effective May 18, 2020, while following Covid-19 mitigation and preventive procedures. Patients must wear a mask covering their nose, mouth and chin. They must come alone. One companion is allowed for children, and patients with disability,…

Coronavirus Covid-19, Sleep Apnea and CPAP What is the relationship between Coronavirus Covid-19, Sleep Apnea, and CPAP? Coronavirus Covid-19 is a new virus that has adapted to infect humans. It is very infective, with each infected patient apparently infecting another two-and-a-half people. It seems harmless for many people, who might not even realize they have…

Coronavirus Covid-19 Sleep and Attention Disorders Institute Response By March 20, 2020, Michigan had become a Covid-19 moderately impacted state. Here is the Coronavirus Covid-19 Sleep and Attention Disorders Institute Response. As Covid-19 began to spread across the USA, we started paying even more attention to hygiene. We have always been very aware of the…

Schedule An Appointment Today

44344 Dequindre Rd Suite 360
Sterling Heights, MI 48314
click here for directions

PHONE: 586.254.0707

FAX: 586.254.7207